6.
Rashid F, Xie Z, Suleman M, Shah A, Khan S, Luo S
. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front Immunol. 2022; 13:940756.
PMC: 9394213.
DOI: 10.3389/fimmu.2022.940756.
View
7.
Levene R, Shrestha S, Gaglia M
. The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner. J Virol. 2021; 95(8).
PMC: 8103685.
DOI: 10.1128/JVI.02312-20.
View
8.
Vankadari N, Jeyasankar N, Lopes W
. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence. J Phys Chem Lett. 2020; 11(22):9659-9668.
DOI: 10.1021/acs.jpclett.0c02818.
View
9.
Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M
. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020; 369(6508):1249-1255.
PMC: 7402621.
DOI: 10.1126/science.abc8665.
View
10.
Tsueng G, Mullen J, Alkuzweny M, Cano M, Rush B, Haag E
. Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resources. Nat Methods. 2023; 20(4):536-540.
PMC: 10393269.
DOI: 10.1038/s41592-023-01770-w.
View
11.
Redondo N, Zaldivar-Lopez S, Garrido J, Montoya M
. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front Immunol. 2021; 12:708264.
PMC: 8293742.
DOI: 10.3389/fimmu.2021.708264.
View
12.
Thorne L, Bouhaddou M, Reuschl A, Zuliani-Alvarez L, Polacco B, Pelin A
. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2021; 602(7897):487-495.
PMC: 8850198.
DOI: 10.1038/s41586-021-04352-y.
View
13.
Gori Savellini G, Anichini G, Gandolfo C, Cusi M
. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion. Viruses. 2022; 14(6).
PMC: 9230033.
DOI: 10.3390/v14061273.
View
14.
Afsar M, Narayan R, Akhtar M, Das D, Rahil H, Nagaraj S
. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2. Elife. 2022; 11.
PMC: 9018067.
DOI: 10.7554/eLife.74877.
View
15.
Lin J, Tang C, Wei H, Du B, Chen C, Wang M
. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe. 2021; 29(3):489-502.e8.
PMC: 7846228.
DOI: 10.1016/j.chom.2021.01.015.
View
16.
Yan W, Zheng Y, Zeng X, He B, Cheng W
. Structural biology of SARS-CoV-2: open the door for novel therapies. Signal Transduct Target Ther. 2022; 7(1):26.
PMC: 8793099.
DOI: 10.1038/s41392-022-00884-5.
View
17.
Tidu A, Janvier A, Schaeffer L, Sosnowski P, Kuhn L, Hammann P
. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation. RNA. 2020; .
PMC: 7901841.
DOI: 10.1261/rna.078121.120.
View
18.
Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng C
. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol. 2008; 82(9):4471-9.
PMC: 2293030.
DOI: 10.1128/JVI.02472-07.
View
19.
Sun Y, Hu Z, Zhang X, Chen M, Wang Z, Xu G
. An R195K Mutation in the PA-X Protein Increases the Virulence and Transmission of Influenza A Virus in Mammalian Hosts. J Virol. 2020; 94(11).
PMC: 7269435.
DOI: 10.1128/JVI.01817-19.
View
20.
Lokugamage K, Narayanan K, Huang C, Makino S
. Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation. J Virol. 2012; 86(24):13598-608.
PMC: 3503042.
DOI: 10.1128/JVI.01958-12.
View